Myriad Helps DuPont AgBio Unit Build a Better Seed | GenomeWeb

NEW YORK, April 3 - Myriad Genetics said today that it was tapped by DuPont to help the chemical giant's agbio division build a better seed.

Myriad will get $24 million over two years to apply its genomic-sequencing technology and bioinformatics experience to collect and deliver certain molecular-genetic information to the unit, Pioneer.

Financial details of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.